Inhibiting casein kinase 2 sensitizes acute lymphoblastic leukemia cells to venetoclax via MCL1 degradation

被引:9
|
作者
Lazaro-Navarro, Juan [1 ,2 ]
Pimentel-Gutierrez, Helia Judith [1 ,2 ]
Gauert, Anton [1 ,2 ]
Hagemann, Anja I. H. [1 ]
Eisenschmid, Jassi [3 ,4 ]
Goekbuget, Nicola [2 ,4 ]
Vick, Binje [2 ,5 ]
Jeremias, Irmela [2 ,5 ]
Seyfried, Felix [6 ]
Meyer, Luder Hinrich [6 ]
Debatin, Klaus-Michael [6 ]
Richer, Kathrin [7 ]
Bultman, Miriam [7 ]
Neumann, Martin [2 ,7 ]
Hanzelmann, Sonja [2 ]
Serve, Hubert [2 ,3 ,4 ]
Astrahantseff, Kathy [1 ]
Rieger, Michael A. [2 ,3 ,4 ]
Eckert, Cornelia [1 ,2 ]
Baldus, Claudia D. [2 ,7 ]
Bastian, Lorenz [2 ,7 ]
机构
[1] Charit Univ med Berlin, Dept Pediat Oncol Hematol, Berlin, Germany
[2] German Canc Res Ctr, German Canc Consortium DKTK, Heidelberg, Germany
[3] Frankfurt Canc Inst, Frankfurt, Germany
[4] Goethe Univ Hosp Frankfurt, Dept Med Hematol Oncol, Frankfurt, Germany
[5] Helmholtz Ctr Munich German Ctr Environm Hlth HMG, Dept Apoptosis Hematopoiet Stem Cells, Munich, Germany
[6] Univ Ulm, Dept Pediat & Adolescent Med, Med Ctr, Ulm, Germany
[7] Univ Med Ctr Schleswig Holstein, Med Dept 2, Hematol Oncol, Campus Kiel, Kiel, Germany
关键词
BCL-2; DEPENDENCE; APOPTOSIS; CK2; ACTIVATION; GENOMICS;
D O I
10.1182/bloodadvances.2021004513
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:5501 / 5506
页数:6
相关论文
共 50 条
  • [31] CD74 Antibody Conjugated to an MCL1 Inhibitor (S227928) Combines Synergistically with Venetoclax to Enhance Killing of Acute Myeloid Leukemia
    Moujalled, Donia M.
    Pomilio, Giovanna
    Morley, Thomas
    Litalien, Veronique
    Anstee, Natasha S.
    Loo, Sun
    Yeoh, Zhi-Han
    Boibessot, Clovis
    Bresson, Laura
    Maragno, Ana-Leticia
    Liot, Caroline
    Wei, Andrew H.
    BLOOD, 2024, 144 : 4136 - 4137
  • [32] Combined inhibition of MCL1 and BCL-2 with AMG 176 and venetoclax induces anti-tumor effects in primary patient samples and models of acute myeloid leukemia
    Caenepeel, Sean R.
    Osgood, Tao
    Belmontes, Brian
    Sun, Jan
    Cajulis, Elaina
    Wei, Andrew
    Coxon, Angela
    Canon, Jude
    Hughes, Paul
    CANCER RESEARCH, 2018, 78 (13)
  • [33] Bone marrow infiltrated natural killer cells predicted the anti-leukemia activity of MCL1 or BCL2 inhibitors in acute myeloid leukemia
    Yu-Jun Dai
    Si-Yuan He
    Fang Hu
    Xue-Ping Li
    Jian-Ming Zhang
    Si-Liang Chen
    Wei-Na Zhang
    Hai-Min Sun
    Da-Wei Wang
    Molecular Cancer, 20
  • [34] Bone marrow infiltrated natural killer cells predicted the anti-leukemia activity of MCL1 or BCL2 inhibitors in acute myeloid leukemia
    Dai, Yu-Jun
    He, Si-Yuan
    Hu, Fang
    Li, Xue-Ping
    Zhang, Jian-Ming
    Chen, Si-Liang
    Zhang, Wei-Na
    Sun, Hai-Min
    Wang, Da-Wei
    MOLECULAR CANCER, 2021, 20 (01)
  • [35] Autophagic HuR mRNA degradation induces survivin and MCL1 downregulation in YM155-treated human leukemia cells
    Chiou, Jing-Ting
    Lee, Yuan-Chin
    Huang, Chia-Hui
    Shi, Yi-Jun
    Wang, Liang-Jun
    Chang, Long-Sen
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2020, 387
  • [36] Tal-1 induces T cell acute lymphoblastic leukemia accelerated by casein kinase II alpha
    Kelliher, MA
    Seldin, DC
    Leder, P
    EMBO JOURNAL, 1996, 15 (19): : 5160 - 5166
  • [37] Inhibiting Mcl-1 with an antisense oligonucleotide induces cell death in acute myeloid leukemia cells
    Carter, Bing Z.
    Mak, Duncan
    Schober, Wendy
    Koller, Erich
    Dean, Nicholas M.
    Marcusson, Eric G.
    Monia, Brett P.
    Andreeff, Michael
    CANCER RESEARCH, 2006, 66 (08)
  • [38] Targeting TPC2 sensitizes acute lymphoblastic leukemia cells to chemotherapeutics by impairing lysosomal function
    Geisslinger, Franz
    Mueller, Martin
    Chao, Yu-Kai
    Grimm, Christian
    Vollmar, Angelika M.
    Bartel, Karin
    CELL DEATH & DISEASE, 2022, 13 (08)
  • [39] Targeting TPC2 sensitizes acute lymphoblastic leukemia cells to chemotherapeutics by impairing lysosomal function
    Franz Geisslinger
    Martin Müller
    Yu-Kai Chao
    Christian Grimm
    Angelika M. Vollmar
    Karin Bartel
    Cell Death & Disease, 13
  • [40] Synergistic Activity of the MCL-1-Specific Inhibitor S63845 with Venetoclax in B-Cell Precursor Acute Lymphoblastic Leukemia
    Seyfried, Felix
    Stirnweiss, Felix
    Koehrer, Stefan
    Debatin, Klaus-Michael
    Meyer, Lueder Hinrich
    BLOOD, 2018, 132